余婷;彭芸花;
YU Ting;PENG Yun-hua;First Clinical Medical College of Lanzhou University;Department of Gynaecology and Obstetrics,The Second Affiliated Hospital of Hainan Medical University;

• 1:兰州大学第一临床医学院
• 2:海南医学院第二附属医院妇产科

摘要(Abstract)：

幽门螺旋杆菌是最常见的消化道致病菌,参与急性胃肠炎、消化性溃疡、胃肠肿瘤等胃肠道疾病的发生发展,与胃肠外疾病也有密切联系。研究发现,幽门螺旋杆菌感染与子痫前期存在明确的流行病学因果关系,特别是细胞毒素相关基因A(cytotoxin-associated gene A, cagA)阳性的幽门螺旋杆菌菌株诱导产生的抗cagA抗体可与滋养层细胞发生免疫反应导致滋养细胞浸润异常。此外,幽门螺旋杆菌感染引起的炎症反应、脂质代谢异常可造成血管内皮功能异常,导致子痫前期。本文将对幽门螺旋杆菌感染与子痫前期的关系作一综述。
Helicobacter pylori is one of the most common pathogenic bacteria of the digestive tract, which is involved in the etiology of acute gastroenteritis, peptic ulcer, gastrointestinal tumor and Parenteral diseases. The epidemiological relationship between Helicobacter pylori and preeclampsia has been confirmed currently. Even tighter association has been found between preeclampsia and infection of cytotoxin-associated gene A(cagA) positive strains of Helicobacter pylori. The anti-caga antibody induced by Helicobacter pylori can have an immune reaction with trophoblast cells, leading to abnormal trophoblast infiltration. In addition, the inflammation and abnormal lipid metabolism caused by Helicobacter pylori can cause abnormal vascular endothelial function, leading to the onset of preeclampsia and the generation of long-term complications. This article reviews the relationship between Helicobacter pylori and preeclampsia and the latest research progress.

关键词(KeyWords)： 幽门螺旋杆菌;子痫前期;抗细胞毒素相关基因A抗体
Helicobacter pylori;preeclampsia;anti-cagA antibody

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 余婷;彭芸花;
YU Ting;PENG Yun-hua;First Clinical Medical College of Lanzhou University;Department of Gynaecology and Obstetrics,The Second Affiliated Hospital of Hainan Medical University;

Email:

DOI:

参考文献(References)：

• [1] Bwj M,Roberts CT,Thangaratinam S,et al.Pre-eclampsia[J].Lancet,2016,387:999- 1011.
• [2] Paauw ND,Luijken K,Franx A,et al.Long-term renal and cardiovascular risk after preeclampsia:Towards screening and prevention[J].Clin Sci(Lond),2016,130:239- 246.
• [3] Possomato-Vieira JS,Khalil RA.Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia[J].Adv pharmacol,2016,77:361- 431.
• [4] Nourollahpour SM,Behboodi MZ,Adam I,et al.Human infectious diseases and risk of preeclampsia:an updated review of the literature[J].Infection,2017,45:589- 600.
• [5] 姚敏,李艳梅.根除幽门螺杆菌四联疗法对胃肠道微生态的影响[J].协和医学杂志,2019,10(3):268- 271.
• [6] Zamani M,Ebrahimtabar F,Zamani V,et al.Systematic review with meta-analysis:the worldwide prevalence of Helicobacter pylori infection[J].Aliment Pharmacol Ther,2018,47:868- 876.
• [7] Nejati S,Karkhah A,Darvish H,et al.Influence of Helicobacter pylori virulence factors CagA and VacA on pathogen-esis of gastrointestinal disorders[J].Microb Pathog,2018,117:43- 48.
• [8] Cardaropoli S,Rolfo A,Piazzese A,et al.Helicobacter pylori's virulence and infection persistence define pre-eclampsia complicated by fetal growth retardation[J].World J Gastroenterol,2011,17:5156- 5165.
• [9] Zhan YL,Si MY,Li MS,et al.The risk of Helicobacter pylori infection for adverse pregnancy outcomes:A systematic review and meta analysis[J].Helicobacter,2019,24:e12562.
• [10] Ponzetto A,Cardaropoli S,Piccoli E,et al.Pre-eclampsia is associated with Helicobacter pylori seropositivity in Italy[J].J Hypertens,2006,24:2445- 2449.
• [11] Ahmed MA,Hassan NG,Omer ME,et al.Helicobacter pylori and Chlamydia trachomatis in Sudanese women with preeclampsia[J].J Mater Fetal Neonatal Med,2020,33:2023- 2026.
• [12] Simone ND,Tersigni C,Cardaropoli S,et al.Helicobacter pylori infection contributes to placental impairment in preeclampsia:basic and clinical evidences[J].Helicobacter,2017,22:e12347.
• [13] den Hollander WJ,Schalekamp-Timmermans S,Holster IL,et al.Helicobacter pylori colonization and pregnancies complicated by preeclampsia,spontaneous prematurity,and small for gestational age birth[J].Helicobacter,2016,22:e12364.
• [14] Elkhouly NI,Elkelani OA,Elhalaby AF,et al.Relation between Helicobacter pylori infection and severe pre-eclampsia complicated by intrauterine growth restriction in a rural area in Egyp[J].J Obstet Gynaecol,2016,36:1046- 1049.
• [15] Mosbah A,Nabiel Y.Helicobacter pylori,Chlamydiae pneumoniae and trachomatis as probable etiological agents of preeclampsia[J].J Mater Fetal Neonatal Med,2016,29:1607- 1612.
• [16] Kuo FC,Wu CY,Kuo CH,et al.The Utilization of a New Immunochromatographic Test in Detection of Helicobacter pylori Antibody from Maternal and Umbilical Cord Serum[J].Biomed Res Int,2014,2014:568410.
• [17] Cardaropoli S,Giuffrida D,Piazzese A,et al.Helicobacter pylori seropositivity and pregnancy-related diseases:a prospective cohort study[J].J Reprod Immunol,2015,109:41- 47.
• [18] üstün Y,Engin-üstün Y,?zkaplan E,et al.Association of Helicobacter pylori infection with systemic inflammation in preeclampsia[J].J Matern Fetal Med,2010,23:311- 314.
• [19] Aksoy H,Ozkan A,Aktas F,et al.Helicobacter pylori seropositivity and its relationship with serum malondialdehyde and lipid profile in preeclampsia[J].J Clin Lab Anal,2010,23:219- 222.
• [20] Pugliese A,Beltramo T,Todros T,et al.Interleukin- 18 and gestosis:correlation with Helicobacter pylori seropositivity[J].Cell Biochemi Funct,2008,26:817- 819.
• [21] Bellos I,Daskalakis G,Pergialiotis V.Helicobacter pylori infection increases the risk of developing preeclampsia:A meta-analysis of observational studies[J].Int J Clin Pract,2018,72:e13064.
• [22] Nourollahpour SM,Mohammad RS,Adam I,et al.Helicobacter pylori infection and risk of preeclampsia:a systematic review and meta-analysis[J].J Matern Fetal Neonatal Med,2019,32:324- 331.
• [23] 郭晗,张云聪,杨硕,等.子痫前期发病机制的研究进展[J].临床检验杂志,2018,36:439- 443.
• [24] Franceschi F,Di Simone N,D'Ippolito S,et al.Antibodies anti-caga cross-react with trophoblast cells:a risk factor for pre-eclampsia?[J].Helicobacter,2012,17:426- 434.
• [25] Qadri Q,Rasool R,Gulzar GM,et al.H.pyloriInfection,Inflammation and Gastric Cancer[J].J Gastrointest Cancer,2014,45:126- 132.
• [26] Buzás GM.Metabolic consequences of Helicobacter pylori infection and eradication[J].World J Gastroenterol,2014,20:5226- 5234.
• [27] Adachi K,Mishiro T,Toda T,et al.Effects of Helicobacter pylori eradication on serum lipid levels[J].J Clin Biochem Nutr,2018,62:264- 269.
• [28] 王广娇,杨孜.脂代谢和脂肪酸代谢与子痫前期[J].中国实用妇科与产科杂志,2018,34:18- 22.
• [29] Adank MC,Benschop L,Peterbroers KR,et al.Is maternal lipid profile in early pregnancy associated with pregnancy complications and blood pressure in pregnancy and long-term postpartum?[J].Am J Obstet Gynecol,2019,221:150.e1- 150.e13.
• [30] Riise HKR,Sulo G,Tell GS,et al.Hypertensive pregnancy disorders increase the risk of maternal cardiovascular disease after adjustment for cardiovascular risk factors[J].Int J Cardiol,2019,282:81- 87.
• [31] Veerbeek JHW,Hermes W,Breimer AY,et al.Cardiovascular disease risk factors after early-onset preeclampsia,late-onset preeclampsia,and pregnancy-induced hypertension[J].Hypertension,2015,65:600- 606.
• [32] Alsnes IV,Vatten LJ,Fraser A,et al.Hypertension in Pregnancy and Offspring Cardiovascular Risk in Young Adulthood Novelty and Significance[J].Hypertension,2017,69:591- 598.
• [33] Davi G,Neri M,Falco A,et al.Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation[J].Arteriosclerosis Thromb Vasc Biol,2005,25:246- 251.
• [34] Franceschi F,Niccoli G,Ferrante G,et al.CagA antigen of Helicobacter pylori and coronary instability:insight from a clinico-pathological study and a meta-analysis of 4241 cases[J].Atherosclerosis,2009,202:535- 542.